PerkinElmer, Inc. Expands Leading Offering of New GPCR Cell Lines for Life Sciences and Drug Discovery Research

LILLE, France--(BUSINESS WIRE)--At the 15th Annual Society for Biomolecular Sciences (SBS) Conference , PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the release of 16 new G-protein coupled receptor (GPCR) and ion channel cell lines. With these latest offerings, PerkinElmer’s GPCR cell lines portfolio is now increased to over 300.

MORE ON THIS TOPIC